Clarient to Sell CombiMatrix's DNAarray Products

Clarient, which is owned by GE Healthcare, gained exclusive rights to commercialize oncology-related tests among commercial laboratories.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.